CRIS Current Research Information System

ANDRISANO, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.254
AS - Asia 12.667
EU - Europa 12.504
AF - Africa 916
SA - Sud America 769
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 35
Totale 42.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.110
CN - Cina 4.203
SG - Singapore 3.645
GB - Regno Unito 3.045
IT - Italia 2.939
VN - Vietnam 2.080
DE - Germania 1.558
SE - Svezia 1.123
UA - Ucraina 954
HK - Hong Kong 896
IN - India 779
RU - Federazione Russa 688
BR - Brasile 559
FR - Francia 504
IE - Irlanda 403
KR - Corea 360
CI - Costa d'Avorio 324
EE - Estonia 230
JP - Giappone 228
ZA - Sudafrica 228
NL - Olanda 224
TG - Togo 150
SC - Seychelles 132
FI - Finlandia 129
BG - Bulgaria 120
CH - Svizzera 116
AR - Argentina 91
CA - Canada 87
ES - Italia 83
ID - Indonesia 79
JO - Giordania 64
PL - Polonia 64
TR - Turchia 59
BE - Belgio 57
HR - Croazia 52
IR - Iran 49
MX - Messico 44
CZ - Repubblica Ceca 41
EC - Ecuador 39
EU - Europa 38
GR - Grecia 38
AT - Austria 34
AU - Australia 29
RO - Romania 28
CL - Cile 26
TW - Taiwan 25
BD - Bangladesh 23
CO - Colombia 23
TH - Thailandia 22
NG - Nigeria 21
PK - Pakistan 21
DK - Danimarca 18
LB - Libano 17
MY - Malesia 17
IQ - Iraq 16
DZ - Algeria 14
PH - Filippine 13
AE - Emirati Arabi Uniti 12
PT - Portogallo 12
PY - Paraguay 11
SA - Arabia Saudita 11
EG - Egitto 10
MA - Marocco 9
UZ - Uzbekistan 9
TN - Tunisia 8
SI - Slovenia 7
VE - Venezuela 7
HU - Ungheria 6
IL - Israele 6
LK - Sri Lanka 6
LT - Lituania 6
AZ - Azerbaigian 5
GT - Guatemala 5
MD - Moldavia 5
NP - Nepal 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
BO - Bolivia 4
CY - Cipro 4
KE - Kenya 4
BA - Bosnia-Erzegovina 3
CM - Camerun 3
HN - Honduras 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
CR - Costa Rica 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NC - Nuova Caledonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SM - San Marino 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 42.166
Salva come PNG Salva come JPEG
Città #
Southend 2.620
Singapore 2.310
Ashburn 1.732
Fairfield 1.324
Chandler 1.176
Santa Clara 889
Hong Kong 873
Hefei 801
Houston 770
Wilmington 746
Bologna 685
Jacksonville 666
Woodbridge 625
Dong Ket 619
Princeton 613
Seattle 559
Ann Arbor 503
Beijing 467
Cambridge 451
Boardman 405
Dublin 402
Ho Chi Minh City 373
Abidjan 324
Hanoi 305
Seoul 299
Nanjing 293
Westminster 268
Padova 264
Berlin 222
Los Angeles 211
Tokyo 209
Jinan 196
Dallas 189
Milan 181
Lomé 150
Shenyang 150
Buffalo 146
Medford 135
Saint Petersburg 130
New York 129
Sofia 115
Changsha 113
Mülheim 112
Turin 105
Guangzhou 104
Redondo Beach 99
Helsinki 97
Falls Church 96
Nanchang 91
Hebei 90
Tianjin 88
Bengaluru 86
Mahé 83
Cesena 82
San Diego 80
Munich 77
Bern 74
Zhengzhou 72
Rome 68
Amman 64
Dearborn 61
Jiaxing 61
Shanghai 61
Redmond 58
São Paulo 57
Bremen 56
Frankfurt am Main 52
Des Moines 50
Haikou 50
Hangzhou 49
Brussels 48
Carpi 48
Jakarta 44
Norwalk 44
Taiyuan 44
Hyderabad 42
Forlì 41
Redwood City 40
Verona 40
Chicago 39
Taizhou 39
Cardiff 38
Haiphong 38
Phoenix 38
Olalla 37
Yubileyny 36
Rimini 32
Nuremberg 31
Brooklyn 30
London 30
Falkenstein 29
Paris 29
Biên Hòa 28
Lanzhou 28
Council Bluffs 27
Hải Dương 27
Ningbo 27
Warsaw 27
Florence 26
Fuzhou 26
Totale 26.814
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 503
A small molecule targeting the multifactorial nature of Alzheimer's disease 465
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 376
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 309
Analisi farmaceutica: metodi di riconoscimento e di separazione 300
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 295
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 290
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 282
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 278
Advanced analytical methodologies in Alzheimer's disease drug discovery 268
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 263
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 238
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 237
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 235
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 231
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 231
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 223
null 222
Influence of high-pressure homogenization treatments combined with lysozyme activated packaging on microbiological and technological quality of vegetable smoothie during shelf life 217
Analisi farmaceutica. Metodi di riconoscimento e di separazione 211
INFLUENCE OF AN INNOVATIVE, BIODEGRADABLE MULTILAYER ACTIVE PACKAGING ON “PESTO” SAUCE CHARACTERISTICS DURING STORAGE 205
Rational Approach to discover multipotent anti-Alzheimer drugs 204
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 201
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 201
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 198
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 193
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 192
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer’s Disease 191
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 188
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 183
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 182
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 181
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 180
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 180
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 179
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 179
Influence of an innovative, biodegradable active packaging on the quality of sunflower oil and “pesto” sauce during storage 178
Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. 175
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 175
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 173
Determination of levamisole and tetramisole in seized cocaine samples by enantioselective high-performance liquid chromatography and circular dichroism detection 172
Determination of dextromethorphan and levomethorphan in seized heroin samples by enantioselective HPLC and electronic CD 170
Development of a new bio-compostable thin film for food packaging with in-line plasma treatment 170
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6 170
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 168
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 168
Monolytic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies 165
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 165
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 164
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease 164
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 163
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 162
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases 162
EcoPackLab: a new laboratory for the development of new food packaging with long shelf life 162
Simultaneous micellar electrokinetic chromatography of adriblastina and tarabine PFS. Their application to some biological fluids. 161
AFM study of F-actin on chemically modified surfaces 161
AFM study of F-actin on chemically modified surfaces 161
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 161
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 161
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action 159
Characterization of reversible and pseudo-irreversible Acetylcholinesterase inhibitors by means of immobilized enzyme reactor 156
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 156
Methotrexate determination in pharmaceuticals by enantioselective HPLC 155
GC-FID/MS method for the impurity profiling of synthetic d-allethrin. 155
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 155
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 154
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 153
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 152
Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids 152
Batch-wise covalent immobilisation of human acetylcholinesterase: kinetic and inhibition spectrophotometric studies 152
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 152
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 151
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates 150
LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines 149
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets 149
Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. 149
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease 149
Stereoselective analysis of allethrin by two dimensional achiral/chiral HPLC with UV/circular dichroism detection 147
CHOOSING THE RIGHT CHROMATOGRAPHIC SUPPORT FOR ENZYME-BASED MICRO-IMERS. 147
Design, Synthesis and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease Modifying Agents for Alzheimer's Disease 147
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 146
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease 146
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 146
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 145
Separation and quantitation of Fructose-6-phosphate and Fructose-1,6-diphosphate by LC-ESI-MS for the evaluation of Fructose-1,6-biphosphatase activity 145
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 145
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 144
METOTREXATE DETERMINATION IN PHARMACEUTICALS BY ENANTIOSELECTIVE HPLC 144
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 144
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 143
DEVELOPMENT AND CHARACTERIZATION OF A PACKED AChE-micro-IMER FOR DRUG DISCOVERY IN ALZHEIMER’S DISEASE 143
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease 143
Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's disease. 142
Analytical approaches in Alzheimer’s disease Drug Discovery 141
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 141
Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors 140
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 139
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 139
Natural products as novel scaffolds for the design of glycogen synthase kinase 3β inhibitors 138
Lipocrine, a multipotent drug for the investigation of Alzheimer's disease 138
Totale 18.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.656 0 0 0 0 0 244 85 404 376 218 226 1.103
2021/20225.246 495 188 279 319 456 339 130 385 278 405 1.032 940
2022/20235.517 588 736 308 723 376 391 143 348 910 230 466 298
2023/20242.500 123 295 174 205 190 367 270 403 72 123 157 121
2024/20256.861 325 1.038 712 466 1.351 357 498 275 96 328 292 1.123
2025/20268.745 1.453 1.937 1.652 1.384 1.881 438 0 0 0 0 0 0
Totale 43.014